Edaravone Injection, Solution
Product Images NDC 68083-501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Edaravone (NDC 68083-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-spl-30mg (Carton Label Spl 30mg)

Carton-label-spl-30mg (Carton Label Spl 30mg)
Edaravone Injection 30 mg/100 mL (0.3 mg/mL) intravenous infusion sterile solution carton label. The label specifies it is a single-dose bag for intravenous infusion over 30 minutes, containing 30 mg edaravone per 100 mL. The carton holds 2 bags of 100 mL each. The label includes inactive ingredients and pH adjustment information. Labeler is Gland Pharma Limited.*
FDA Label Image

Carton-label-spl-60mg (Carton Label Spl 60mg)

Carton-label-spl-60mg (Carton Label Spl 60mg)
Edaravone Injection 60 mg/100 mL (0.6 mg/mL) sterile solution for intravenous infusion is shown on a folded carton label. It is a single-dose 100 mL bag containing 60 mg active edaravone with inactive ingredients including L-cysteine hydrochloride hydrate, sodium bisulfite, sodium chloride, phosphoric acid, and sodium hydroxide. The labeler is Gland Pharma Limited.*
FDA Label Image

Edaravone-spl-bag-30mg (Edaravone Spl Bag 30mg)

Edaravone-spl-bag-30mg (Edaravone Spl Bag 30mg)
Edaravone Injection 30 mg/100 mL (0.3 mg/mL) intravenous solution in a single-dose bag. The label details active and inactive ingredients, storage instructions, usage precautions, and manufacturer information for Gland Pharma Limited. It is intended for intravenous infusion and includes directions on dosage handling and disposal.*
FDA Label Image

Edaravone-spl-bag-60mg (Edaravone Spl Bag 60mg)

Edaravone-spl-bag-60mg (Edaravone Spl Bag 60mg)
Edaravone Injection 60 mg/100 mL (0.6 mg/mL) intravenous infusion solution in a 100 mL single-dose bag. The label lists active ingredient (60 mg edaravone), inactive ingredients, storage instructions, and manufacturer information (Gland Pharma Limited, India). It includes dosage, caution, usage guidelines, and a barcode. NDC 68083-501-01 is visible.*
FDA Label Image

Edaravone-spl-figure (Edaravone Spl Figure)

Edaravone-spl-figure (Edaravone Spl Figure)
Bar chart comparing percentage of patients for edaravone injection versus placebo based on change in ALSFRS-R score at Week 24. The x-axis shows ranges of ALSFRS-R change scores from worse to better. The y-axis indicates the percent of patients falling within each score range. Edaravone data bars are black, placebo bars are white.*
FDA Label Image

Edaravone-spl-pouch-30mg (Edaravone Spl Pouch 30mg)

Edaravone-spl-pouch-30mg (Edaravone Spl Pouch 30mg)
The image shows the drug facts and usage instructions for Edaravone Injection 30 mg/100 mL (0.3 mg/mL) for intravenous infusion. It includes active and inactive ingredients, dosage directions, cautions, usage, storage conditions, and attention notes related to the product's oxygen indicator and packaging. Manufacturer details and barcode are also visible.*
FDA Label Image

Edaravone-spl-pouch-60mg (Edaravone Spl Pouch 60mg)

Edaravone-spl-pouch-60mg (Edaravone Spl Pouch 60mg)
Edaravone Injection 60 mg/100 mL (0.6 mg/mL) single-dose bag for intravenous infusion. Label includes dosage instructions, cautions, storage conditions, and handling warnings. Manufacturer is Gland Pharma Limited, Hyderabad, India. Features NDC 68083-501-01, lot and expiration placeholders, bar code, and safety information including oxygen indicator details and discard instructions.*
FDA Label Image

Edaravone-spl-structure (Edaravone Spl Structure)

Edaravone-spl-structure (Edaravone Spl Structure)
Chemical structure of edaravone, showing a pyrazolone ring with a phenyl group and methyl substitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.